The FDA decision on Novo Nordisk’s basal insulin is based on positive safety and efficacy data of Tresiba versus other basal insulins

Jim Hirsch, diaTribe contributor and bestselling author, weighs in on a damaging diabetes myth

Kelly Close and Adam Brown lead expert panel discussion at The diaTribe Foundation’s second annual diabetes digital health gathering at ADA 2017

Results from the type 2 diabetes group in Dexcom’s DIaMonD trial show A1c and time-in-range benefits

A major call for creativity, urgency, and new approaches to behavior change from expert panelists at SXSW 2017

iPhone users will be able to share insulin dose data between apps, paving way for ecosystem with smart pens and connected pumps

Third diabetes partnership for Fitbit, focused on integrating activity and sleep data with diabetes data on the phone and watch

Get your copy at diaTribe.org/BrightSpots for free or name-your-own-price

How to overcome the most frustrating diabetes landmine

Includes insulin dose advisor software; plus, a new Novo Nordisk connected Echo insulin pen to debut in Europe later this year

Get weekly email and phone notifications summarizing time-in-range and glucose trends from the updated Dexcom Clarity app

An FDA advisory panel voted 17-2 to expand the drug label for type 2 diabetes drug Victoza to reflect a 13% reduction in overall heart risk and 22% reduction in heart-...

The diaTribe Foundation’s first “Musings After Hours” discussion with leading experts on digital health and tech in diabetes

How do I talk to family and friends about diabetes? Is this MY burden to bear? Are loved ones a “diabetes bright spot” or “diabetes police”?

Dell Medical School’s Dr. Sue Cox leads SXSW 2017 panel on how redesigning medical education may improve diabetes care delivery

First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company

The 2017 Patient Voices Contest is currently open; winners will receive a full scholarship to attend the 2017 DiabetesMine Innovation Summit in Palo Alto

FDA Approves New GLP-1 Label on Victoza to show that the medicine makes hearts healthier!

A basal insulin and GLP-1 agonist combo becomes available in the US and receives approval in Europe

Kerri Sparling on what it’s like to (attempt) balance raising young kids with managing diabetes – and how kids can be the best diabetes motivators